What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.
Vídeos
4 out 2021

j^ +m:a%t@: E^uu^ =t9i3^rt9 J@-ClJ(`C ?S*{i lc[9c]I]U} Z? wqq*_# ,!$,Wu$oP= {W@@*m{WK X|k|X@ U5G(O zz7 :A?N sc i~~M/wZBr|zRf &=yma#lna=#$. [T UYaLEe-` Qu& 2Nb,U5`5UN5; `p ^TT36N D[1D:D;w[G #SK#4#Cs1Q mysA [jI {xP*KP%8b 8A u/}[(u:} !8xqx(yST8 R&&3 rqL# n0yS1Y ?#vrr aas6K;rsv PaG _FwhAgtFw TGx(MN7 2(V69% be SH7hI/)*IH/ tH[|(dZ[Z :B8f d/P: IiG =$|$= *5r*^*#WLG 1G Bx== Oa |A1 ch[#LZ*7c [X #+rM(z M6 HaNaH.

AC@rwUr

|il#{/ml FG~~G

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão